|
|
|
Insider
Information: |
Mackaness James H |
Relationship: |
|
City: |
Mountain View |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
108,005 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$138,478 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
108,005 |
|
|
Total
Value |
$138,478 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
3
|
0
|
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
Percentage
Gain/Loss : |
-65.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Iridex Corp |
IRIX |
CFO and COO |
2015-08-19 |
45,052 |
2009-03-13 |
0 |
Premium* |
|
Invuity, Inc. |
IVTY |
Chief Financial Officer |
2018-10-23 |
0 |
2016-05-18 |
0 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2024-04-01 |
62,953 |
2020-01-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SLNO |
Soleno Therapeutics Inc |
CHIEF FINANCIAL OFFICER |
|
2024-04-01 |
4 |
S |
$41.12 |
$213,937 |
D/D |
(5,175) |
62,953 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
56,000 |
68,128 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2023-12-11 |
4 |
S |
$35.49 |
$1,182,828 |
D/D |
(32,482) |
12,128 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2023-12-11 |
4 |
OE |
$2.60 |
$38,925 |
D/D |
15,000 |
44,610 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2023-11-30 |
4 |
S |
$28.65 |
$119,937 |
D/D |
(4,186) |
21,303 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2023-11-29 |
4 |
S |
$27.43 |
$116,986 |
D/D |
(4,203) |
25,489 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2023-11-28 |
4 |
S |
$27.03 |
$105,190 |
D/D |
(3,878) |
29,692 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2023-10-02 |
4 |
OE |
$1.75 |
$24,497 |
D/D |
8,309 |
41,879 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
29,084 |
33,570 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
40,000 |
67,295 |
2.66 |
% |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2021-09-13 |
4 |
B |
$0.89 |
$9,981 |
D/D |
11,235 |
27,295 |
2.74 |
% |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2020-06-26 |
4 |
B |
$1.65 |
$9,999 |
D/D |
6,060 |
16,060 |
2.74 |
% |
|
SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
|
2020-01-23 |
4 |
A |
$3.35 |
$33,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2018-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(44,399) |
0 |
0 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2018-03-16 |
4 |
B |
$3.90 |
$9,848 |
D/D |
2,528 |
44,399 |
2.74 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
34,800 |
41,871 |
0 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2018-02-15 |
4 |
D |
$4.10 |
$5,396 |
D/D |
(1,316) |
7,071 |
0 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
8,387 |
0 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2017-02-15 |
4 |
D |
$7.80 |
$10,241 |
D/D |
(1,313) |
5,387 |
0 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
6,700 |
0 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2016-11-08 |
4 |
B |
$5.75 |
$9,775 |
D/D |
1,700 |
3,700 |
2.74 |
- |
|
IVTY |
Invuity, Inc. |
Chief Financial Officer |
|
2016-05-18 |
4 |
B |
$5.08 |
$10,155 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
IRIX |
Iridex Corp |
CFO and COO |
|
2015-08-19 |
4 |
S |
$7.15 |
$16,967 |
D/D |
(2,373) |
45,052 |
0 |
- |
|
IRIX |
Iridex Corp |
CFO and COO |
|
2015-08-19 |
4 |
OE |
$4.31 |
$8,098 |
D/D |
1,879 |
46,931 |
0 |
- |
|
IRIX |
Iridex Corp |
CFO and COO |
|
2015-08-18 |
4 |
S |
$7.10 |
$18,658 |
D/D |
(2,627) |
44,558 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|